As of Aug 25
| -0.07 / -2.36%|
The 7 analysts offering 12-month price forecasts for ImmunoGen Inc have a median target of 6.00, with a high estimate of 20.00 and a low estimate of 2.50. The median estimate represents a +106.90% increase from the last price of 2.90.
The current consensus among 8 polled investment analysts is to Hold stock in ImmunoGen Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.